HOME >> MEDICINE >> NEWS
Clinical Trials Units selected for newly restructured HIV/AIDS research networks

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), today announced 60 U.S. and international institutions selected as HIV/AIDS Clinical Trials Units (CTUs) in a newly restructured system of six HIV/AIDS clinical research networks. NIAID expects to fund additional CTUs within the next several months, bringing the total to 73.

These Clinical Trials Units will carry out the next generation of HIV/AIDS vaccine, prevention and treatment research, says NIAID Director Anthony S. Fauci, M.D. They will work with our clinical research networks in a flexible, collaborative and coordinated way to tackle the critical research questions that can help accelerate progress against the HIV/AIDS pandemic. NIAID supports the worlds largest HIV/AIDS clinical research effort.

The CTU awards represent the second step of a two-part restructuring process of NIAIDs HIV/AIDS clinical trials networks. NIAID announced the clinical investigators and institutions responsible for leading the new networks in June 2006 (see http://www3.niaid.nih.gov/news/newsreleases/2006/leadership.htm).

Each CTU is a member of one or more of the six NIAID HIV/AIDS networks: the AIDS Clinical Trials Group, the HIV Prevention Trials Network, the HIV Vaccine Trials Network, the International Maternal Pediatric Adolescent AIDS Clinical Trials Network, the International Network for Strategic Initiatives in Global HIV Trials, and the Microbicide Trials Network.

The HIV/AIDS networks and their CTUs will pursue an integrated research approach to conducting clinical trials designed to address the highest priorities in HIV/AIDS research, including

  • Developing a safe and effective HIV vaccine

  • Conducting research for new drug development designed to translate lab findings into clinical applications


'"/>

Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
12-Mar-2007


Page: 1 2 3

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
6. Clinical guidelines for blood conservation during cardiac procedures developed
7. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
8. Clinical trial coordinators need more financial conflict-of-interest training
9. Clinical studies evaluate potential treatments for mouth ulcers
10. NIH names Clinical Trial Units for the Microbicide Trials Network
11. Study in recent issue of Clinical Pediatrics helps pediatricians to understand discipline practices

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... Somerset, N.J. (PRWEB) , ... September 25, 2017 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... workshops on the development and validation of bioassays at two upcoming conferences. , ...
(Date:9/25/2017)... , ... September 25, 2017 , ... ... affiliated with NCPDP, announced today that it has awarded a $40,000 grant to ... NCPDP’s SCRIPT Standard for ePrescribing. CancelRx enables prescribers to electronically cancel a prescription ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... to improve quality and efficiency. The principle of First-Defect-Stop for laboratory weighing ... results before they have the chance to have negative consequences on downstream processes. ...
(Date:9/25/2017)... Doylestown, Pa. (PRWEB) , ... ... ... world-leading provider of specialized science and technology-enabled services supporting clinical research, today ... of topics addressing key aspects of the drug development lifecycle at upcoming ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... why retirement is not an option to senior, upper-level executives speaking at a ... , "A senior, high-level executive is an asset to be fully realized ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... NEW YORK , Sept. 8, 2017 ... largest independent supplier of medical equipment, supplies, drugs, ... that it has entered into an agreement to acquire ... surgical equipment based in Holtsville, New York ... which specializes in supplying new and emerging medical practices, ...
(Date:9/7/2017)... , Sept. 7, 2017  For nearly two decades, New Life Agency ... Assisted Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)... WARSAW, Ind. , Sept. 7, 2017  Zimmer ... leader in musculoskeletal healthcare, today announced that it will ... Annual Global Healthcare Conference at the Grand Hyatt hotel ... September 11, 2017 at 11:40 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
Breaking Medicine Technology:
Cached News: